Antimuscarinic (Mydriatic)
Pregnancy: Caution — limited data; avoid prolonged use
Tropicamide
Brand names: Mydriacyl
Adult dose
Dose: Fundus examination: 1 drop of 1% solution per eye, 15–20 min before examination. Repeat if needed.
Route: Topical ophthalmic
Frequency: As required for examination
Max: 2 drops per eye per examination
Short-acting (effects last 4–8h). For pupil dilation before fundoscopy, retinal photography, ophthalmoscopy. Warn patients about blurred near vision and photosensitivity — do not drive for 4–8h.
Paediatric dose
Route: Ophthalmic
Frequency: As needed for examination
Max: 0.5% (1 drop) for children (lower concentration)
Concentration: 0.5% or 1% solution drop/ml
Children: use 0.5% solution. Neonates: systemic toxicity risk — 0.5% or lower; press nasolacrimal duct after instillation. Premature infants: specialist assessment before using dilating drops.
Dose adjustments
Renal
N/A
Hepatic
N/A
Clinical pearls
- Angle-closure precipitation: rare but important — always screen for shallow anterior chamber before dilating; do not dilate if suspected angle-closure
- Duration counselling: warn patient blurred vision for 4–8h — no driving, reading may be difficult; come with a companion if possible
- Neonatal systemic effects: fever, tachycardia, vasodilation — report to neonatologist if concerning
- Cyclopentolate (stronger, longer-acting) or atropine (longer-acting): used for cycloplegia (refraction)
Contraindications
- Suspected narrow-angle glaucoma
- Anterior chamber angle closure (acute angle-closure glaucoma risk)
Side effects
- Photophobia and blurred vision (4–8h)
- Transient IOP rise (rarely triggers angle-closure glaucoma in susceptible patients)
- Systemic antimuscarinic effects (especially in children): tachycardia, fever, flushing, dry mouth
- Psychosis-like agitation (in overdose)
Interactions
- Other antimuscarinics — additive systemic effects
Monitoring
- IOP in susceptible patients (narrow angles)
- Visual acuity recovery post-examination
Reference: BNFc; BNF; BNF for Children; RCOphth Examination Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme